Remiges BioPharma Fund, LP is a venture capital fund based in Cambridge, Massachusetts. According to its most recent Form D, filed Mar 9, 2017, it has sold $80,000,000 of interests to 4 investors since its first sale in Jun 2014. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Remiges Biopharma Fund GP, Inc; Walter Olesiak; Taro Inaba.
- Total raised
- $80,000,000Cumulative sales reported on Form D
- Investors
- 4
- First sale
- Jun 6, 2014
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Remiges Biopharma Fund GP, Inc; Walter Olesiak; Taro Inaba
- Latest Form D
- Mar 9, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Mar 9, 2017 | Form D/A (amendment) | $80,000,000 | 4 | SEC.gov ↗ |
| Jul 8, 2014 | Form D/A (amendment) | $70,000,000 | 3 | SEC.gov ↗ |
| Jun 4, 2014 | Form D | $0 | 0 | SEC.gov ↗ |
3 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 4, 2014. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Remiges BioPharma Fund, LP
What is the minimum investment for Remiges BioPharma Fund, LP?
Remiges BioPharma Fund, LP's latest Form D, filed Mar 9, 2017, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Remiges BioPharma Fund, LP?
Remiges BioPharma Fund, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Remiges BioPharma Fund, LP raised?
Remiges BioPharma Fund, LP reports $80,000,000 sold from 4 investors on its Form D filed Mar 9, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is Remiges BioPharma Fund, LP based?
Remiges BioPharma Fund, LP is based in Cambridge, Massachusetts.
When did Remiges BioPharma Fund, LP launch?
Remiges BioPharma Fund, LP reports its first sale in Jun 2014.
Size compared with every venture capital fund
Raised more than 93% of the 531 venture capital funds based in Massachusetts, and more than 97% of all 14,865 that report sales.